Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesA randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines
Clinical and Experimental Dermatology, 11/10/09
Katoulis AC et al. – Undecylenoyl phenylalanine 2% is a novel depigmenting agent, which possibly acts as an alpha–melanocyte–stimulating hormone antagonist, thus inhibiting melaninogenesis. It achieved a significant lightening of the lesions with minimal side–effects. Most patients were satisfied with the improvement. Undecylenoyl phenylalanine 2% may represent a safe, effective and inexpensive therapeutic alternative for solar lentigines.
Related Articles
Long-term and recent recreational physical activity and survival after breast cancer: The California Teachers Study
Cancer Epidemiology, Biomarkers & Prevention, 10/26/09
Relevance Score: 47%
Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP Diet and Health Study
BMC Cancer, 10/05/09
Relevance Score: 47%
Gender and age-specific seasonal variations in physical activity among adults
Journal of Epidemiology and Community Health, 10/29/09
Relevance Score: 46%
Capillary Endothelial Na+, K+, ATPase Transporter Homeostasis and a New Theory for Migraine Pathophysiology
Headache: The Journal of Head and Face Pain, 10/27/09
Relevance Score: 46%
DNase1 activity in systemic lupus erythematosus patients with and without nephropathy
Rheumatology International, 10/26/09
Relevance Score: 46%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Homoeopathic versus Conventional Therapy for Atopic Eczema in Children: Medical and Economic Results
Dermatology, 12/04/09
Non-psoriatic dermatologic uses of monoclonal antibody therapy
Journal of Dermatological Treatment , 12/04/09
Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: A randomized clinical study
Journal of Dermatological Treatment , 12/04/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma
Medical Oncology, 12/04/09
Cutaneous lymphangioma circumscriptum: frog spawn on the skin
International Journal of Dermatology, 12/03/09
Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
Cancer Epidemiology, 12/03/09
Today in Photodermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Effect of Aminolevulinic Acid Photodynamic Therapy on Microcomedones and Macrocomedones
Dermatology, 12/04/09
Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients
British Journal of Dermatology, 12/01/09
Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy
Journal of the European Academy of Dermatology and Venereology, 11/24/09
Sponsor
Article Search
Sponsor